Immunohistochemical staining also showed similar results; patients whose localized colorectal tumors were BRG1-strong had a significantly higher CD44 expression than those with BRG1-moderate tumors (Fig. 5c). This evidence concerns the gene SMARCA4 and colorectal neoplasm.